investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Deprive prostate cancer of DHEAS to prevent castration-recurrent prostate cancer
Yue Wu
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Yue Wu
Roswell Park Cancer Institute
Buffalo, United States
Related projects
Ron Kikinis
Quantitative Image Informatics for Cancer Research (QIICR)
Prostate
Howard I Scher
SPORE In Prostate Cancer
Prostate
Norman Wolmark
NRG Oncology Network Group Operations Center
Prostate
Radiation Oncology
Surgery / Surgical oncology
Hyung L Kim
Qualifying Multi-Transcript Signatures for Active Surveillance of Prostate Cancer
Prostate
Radiation Oncology
Pathology
Ruth D Etzioni
PROMISS - Prostate Modeling to Identify Surveillance Strategies
Prostate
Pathology
Patricia Jean Johnson
Trichomonas vaginalis exosomes: Mediators of host:pathogen interactions
Prostate
Pathology
David Alan Bader
Functional Investigation of the Mitochondrial Pyruvate Carrier in Prostate Cancer
Prostate
Pathology
Mark A Rubin
Towards Understanding Prostate Cancer Heterogeneity
Prostate
Pathology
Clare M Tempany
Enabling Technologies For MRI-Guided Prostate Interventions
Prostate
Pathology